Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2094040 | 0.98 | USP2 (0.40) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL16447201 | 0.98 | USP2 (0.40) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL2284853 | 0.98 | USP2 (0.40) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL1287846 | 0.97 | USP2 (0.39) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL30361807 | 0.90 | USP2 (0.37) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL28609548 | 0.84 | USP2 (0.31) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL29198910 | 0.82 | — | — | |
| SCHEMBL5497063 | 0.77 | USP2 (0.44) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL6158201 | 0.71 | CYP2C19 (0.54) | USP2ALDH1A1LMNACYP1A2TSHR | |
| SCHEMBL29973085 | 0.70 | CYP2C19 (0.42) | USP2ALDH1A1LMNACYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8871180-B2 | Organic-inorganic hybrid particles containing contrast agent | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2014-10-28 | — | — | US | claimed |
| US-20100278737-A1 | ORGANIC-INORGANIC HYBRID PARTICLES CONTAINING CONTRAST AGENT | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-11-04 | — | — | US | claimed |
| US-7045592-B2 | Processes for coupling amino acids using bis-(trichloromethyl) carbonate | DEVELOGEN ISRAEL LTD. (IL) | 2006-05-16 | — | — | US | disclosed |
| EP-1097164-A4 | PROCESSES FOR COUPLING AMINO ACIDS USING BIS-(TRICHLOROMETHYL) CARBONATE | PEPTOR LTD (IL) | 2005-05-25 | — | — | EP | disclosed |
| US-20030195331-A1 | Processes for coupling amino acids using bis-(trichloromethyl) carbonate | PEPTOR LTD. (IL) | 2003-10-16 | — | — | US | disclosed |
| US-6512092-B2 | Solid phase peptide synthesis; in situ generation of amino acid chloride by deblocking; coupling sterically hindered amino acid residues | PEPTOR LTD. (IL) | 2003-01-28 | — | — | US | disclosed |
| US-20010007037-A1 | Processes for coupling amino acids using bis-(trichloromethyl) carbonate | FALB ELIEZER (IL) | 2001-07-05 | — | — | US | disclosed |
| EP-1097164-A1 | PROCESSES FOR COUPLING AMINO ACIDS USING BIS-(TRICHLOROMETHYL) CARBONATE | PEPTOR LTD (IL) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000002898-A1 | PROCESSES FOR COUPLING AMINO ACIDS USING BIS-(TRICHLOROMETHYL) CARBONATE | PEPTOR LTD. (IL) | 2000-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010007037-A1 | Processes for coupling amino acids using bis-(trichloromethyl) carbonate | PTMS, BCAT1, DAO | USP2 1913/4885ALDH1A1 4814/4885LMNA 3658/4885 |
| US-20100278737-A1 | ORGANIC-INORGANIC HYBRID PARTICLES CONTAINING CONTRAST AGENT | CA2, CA3, CA12 | USP2 2507/4885ALDH1A1 4796/4885LMNA 3721/4885 |
| US-20030195331-A1 | Processes for coupling amino acids using bis-(trichloromethyl) carbonate | PTMS, BCAT1, DAO | USP2 1913/4885ALDH1A1 4814/4885LMNA 3658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.